3 Top Dividend Kings to Buy for the Long Haul

07:25am, Monday, 20'th Feb 2023
These companies have more than 150 years of dividend growth between them.
The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories' baby-formula business, the company said.
The SEC's enforcement division sent a subpoena to Abbott in December requesting information about its powder infant-formula business and related public disclosures, the company said Friday in a securi
A new study published in Science Translational Medicine could introduce a profitable opportunity for makers of seizure drug medications. The discovery has immense medical implications, of course, but
Abbott Laboratories expands its cardiovascular pipeline with the relatively small acquisition of Cardiovascular Systems, Inc. Cardiovascular Systems investors get a way out of a cash-burning stock at
"It's a layup for a misdemeanor charge," a food safety attorney told Crain's Chicago, though a felony would be harder for investigators to prove.
Investor sentiment has improved this year on expectations of less-aggressive interest rate hikes by the Federal Reserve to tame inflation. However, the ongoing macro uncertainty continues to create co
ABT has been growing its dividends for OVER half a century and is one of only 37 US stocks to do so. We examine if ABT has ample elbow room to service the dividend.
These stocks may reward you over time.
Abbott's (ABT) latest deal will help gain access to Cardiovascular System's leading atherectomy device to treat vascular disease.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

The Dividend Aristocrats Ranked By Quality Scores

09:30am, Saturday, 11'th Feb 2023
The annual rebalancing and subsequent changes to the S&P 500 Dividend Aristocrats Index have produced a new list of 67 dividend growth stocks called the Dividend Aristocrats. I rank the Dividend Arist
Three companies have been removed from my watchlist and added to the active portfolio. I added four new companies to my watchlist.
Abbott (NYSE: ABT) is buying Cardiovascular Systems (CSI). These are the details.
Cardiovascular Systems CSII, -1.99% shares rose 47% to $19.58 in early premarket trade after Abbott ABT, -1.60% agreed to buy the company for $890 million, or $20 per share. CSI is a leader in devices
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE